STABIL LYOFILISERET FORMULERING TIL HYBRID FC-FUSIONERET G-CSF

The present formulation comprises a stable lyophilized formulation, suitable for administration via a subcutaneous (SC) route, comprising Fc fused to Granulocyte Colony Stimulating Factor (G-CSF) molecules via peptide bond, stabilizer, surfactant and buffer, at pH value of the preparation that is be...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PINARBASLI, Onur, Sahin, Adem, SARRACOGLU, Nagehan, Özkan, Aylin, Çorbacioglu Pala, Meltem, Öncel, Hatice, Daglikoca, Emine Duygu
Format: Patent
Sprache:dan
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator PINARBASLI, Onur
Sahin, Adem
SARRACOGLU, Nagehan
Özkan, Aylin
Çorbacioglu Pala, Meltem
Öncel, Hatice
Daglikoca, Emine Duygu
description The present formulation comprises a stable lyophilized formulation, suitable for administration via a subcutaneous (SC) route, comprising Fc fused to Granulocyte Colony Stimulating Factor (G-CSF) molecules via peptide bond, stabilizer, surfactant and buffer, at pH value of the preparation that is between 3.8 and 5.2.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DK3744319TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DK3744319TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DK3744319TT33</originalsourceid><addsrcrecordid>eNrjZLALDnF08vRR8In0d_P08Qx2DXINUXDzD_IN9XEN8vRzVwgBSnpEOgV5uii4Oeu6hQZ7-vuBFbnrOge78TCwpiXmFKfyQmluBkU31xBnD93Ugvz41OKCxOTUvNSSeBdvY3MTE2NDy5AQY2Ni1AAAesIqrA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>STABIL LYOFILISERET FORMULERING TIL HYBRID FC-FUSIONERET G-CSF</title><source>esp@cenet</source><creator>PINARBASLI, Onur ; Sahin, Adem ; SARRACOGLU, Nagehan ; Özkan, Aylin ; Çorbacioglu Pala, Meltem ; Öncel, Hatice ; Daglikoca, Emine Duygu</creator><creatorcontrib>PINARBASLI, Onur ; Sahin, Adem ; SARRACOGLU, Nagehan ; Özkan, Aylin ; Çorbacioglu Pala, Meltem ; Öncel, Hatice ; Daglikoca, Emine Duygu</creatorcontrib><description>The present formulation comprises a stable lyophilized formulation, suitable for administration via a subcutaneous (SC) route, comprising Fc fused to Granulocyte Colony Stimulating Factor (G-CSF) molecules via peptide bond, stabilizer, surfactant and buffer, at pH value of the preparation that is between 3.8 and 5.2.</description><language>dan</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230116&amp;DB=EPODOC&amp;CC=DK&amp;NR=3744319T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230116&amp;DB=EPODOC&amp;CC=DK&amp;NR=3744319T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PINARBASLI, Onur</creatorcontrib><creatorcontrib>Sahin, Adem</creatorcontrib><creatorcontrib>SARRACOGLU, Nagehan</creatorcontrib><creatorcontrib>Özkan, Aylin</creatorcontrib><creatorcontrib>Çorbacioglu Pala, Meltem</creatorcontrib><creatorcontrib>Öncel, Hatice</creatorcontrib><creatorcontrib>Daglikoca, Emine Duygu</creatorcontrib><title>STABIL LYOFILISERET FORMULERING TIL HYBRID FC-FUSIONERET G-CSF</title><description>The present formulation comprises a stable lyophilized formulation, suitable for administration via a subcutaneous (SC) route, comprising Fc fused to Granulocyte Colony Stimulating Factor (G-CSF) molecules via peptide bond, stabilizer, surfactant and buffer, at pH value of the preparation that is between 3.8 and 5.2.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLALDnF08vRR8In0d_P08Qx2DXINUXDzD_IN9XEN8vRzVwgBSnpEOgV5uii4Oeu6hQZ7-vuBFbnrOge78TCwpiXmFKfyQmluBkU31xBnD93Ugvz41OKCxOTUvNSSeBdvY3MTE2NDy5AQY2Ni1AAAesIqrA</recordid><startdate>20230116</startdate><enddate>20230116</enddate><creator>PINARBASLI, Onur</creator><creator>Sahin, Adem</creator><creator>SARRACOGLU, Nagehan</creator><creator>Özkan, Aylin</creator><creator>Çorbacioglu Pala, Meltem</creator><creator>Öncel, Hatice</creator><creator>Daglikoca, Emine Duygu</creator><scope>EVB</scope></search><sort><creationdate>20230116</creationdate><title>STABIL LYOFILISERET FORMULERING TIL HYBRID FC-FUSIONERET G-CSF</title><author>PINARBASLI, Onur ; Sahin, Adem ; SARRACOGLU, Nagehan ; Özkan, Aylin ; Çorbacioglu Pala, Meltem ; Öncel, Hatice ; Daglikoca, Emine Duygu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DK3744319TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>dan</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>PINARBASLI, Onur</creatorcontrib><creatorcontrib>Sahin, Adem</creatorcontrib><creatorcontrib>SARRACOGLU, Nagehan</creatorcontrib><creatorcontrib>Özkan, Aylin</creatorcontrib><creatorcontrib>Çorbacioglu Pala, Meltem</creatorcontrib><creatorcontrib>Öncel, Hatice</creatorcontrib><creatorcontrib>Daglikoca, Emine Duygu</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PINARBASLI, Onur</au><au>Sahin, Adem</au><au>SARRACOGLU, Nagehan</au><au>Özkan, Aylin</au><au>Çorbacioglu Pala, Meltem</au><au>Öncel, Hatice</au><au>Daglikoca, Emine Duygu</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>STABIL LYOFILISERET FORMULERING TIL HYBRID FC-FUSIONERET G-CSF</title><date>2023-01-16</date><risdate>2023</risdate><abstract>The present formulation comprises a stable lyophilized formulation, suitable for administration via a subcutaneous (SC) route, comprising Fc fused to Granulocyte Colony Stimulating Factor (G-CSF) molecules via peptide bond, stabilizer, surfactant and buffer, at pH value of the preparation that is between 3.8 and 5.2.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language dan
recordid cdi_epo_espacenet_DK3744319TT3
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title STABIL LYOFILISERET FORMULERING TIL HYBRID FC-FUSIONERET G-CSF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T12%3A19%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PINARBASLI,%20Onur&rft.date=2023-01-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDK3744319TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true